Key result
Plasmapheresis successfully restored left ventricular ejection fraction to 53% and allowed for ECMO decannulation in a patient with severe lupus myocarditis and refractory cardiogenic shock.
Case Report (n=1)
No
Plasmapheresis may serve as an effective rescue therapy for severe, refractory cardiogenic shock secondary to systemic lupus erythematosus myocarditis.
May warrant plasmapheresis consideration in refractory lupus shock; single case leaves open need for prospective trials.
A 25-year-old woman with systemic lupus erythematosus complicated by biventricular failure with a history of multiple admissions presented with cardiogenic shock unresponsive to steroids, intravenous immunoglobulin, cyclophosphamide, and required extra-corporeal membrane oxygenation. Left ventricular function eventually recovered after plasmapheresis. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Smith et al. (2020) conducted a case report in Systemic lupus erythematosus myocarditis with cardiogenic shock (n=1). Plasmapheresis was evaluated on Left ventricular ejection fraction (LVEF) recovery. Plasmapheresis successfully restored left ventricular ejection fraction to 53% and allowed for ECMO decannulation in a patient with severe lupus myocarditis and refractory cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: